Cargando…
Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (st...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645538/ https://www.ncbi.nlm.nih.gov/pubmed/32086574 http://dx.doi.org/10.1007/s00330-020-06726-8 |
_version_ | 1784610325925986304 |
---|---|
author | Auer, Timo Alexander Fehrenbach, Uli Grieser, Christian Penzkofer, Tobias Geisel, Dominik Schmelzle, Moritz Müller, Tobias Bläker, Hendrik Seehofer, Daniel Denecke, Timm |
author_facet | Auer, Timo Alexander Fehrenbach, Uli Grieser, Christian Penzkofer, Tobias Geisel, Dominik Schmelzle, Moritz Müller, Tobias Bläker, Hendrik Seehofer, Daniel Denecke, Timm |
author_sort | Auer, Timo Alexander |
collection | PubMed |
description | PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (standard of reference: surgical resection). Two blinded radiologists performed quantitative measurements (lesion-to-liver enhancement) and evaluated qualitative imaging features. Inter-reader variability was tested. Advanced texture analysis was used to evaluate lesion heterogeneity three-dimensionally. RESULTS: Overall, there were 19 (24%) hepatocyte nuclear factor (HNF)-1a-mutated (HHCAs), 37 (47%) inflammatory (IHCAs), 5 (6.5%) b-catenin-activated (bHCA), and 18 (22.5%) unclassified (UHCAs) adenomas. In the hepatobiliary phase (HBP), 49.5% (39/79) of all adenomas were rated as hypointense and 50.5% (40/79) as significantly enhancing (defined as > 25% intralesional GD-EOB uptake). 82.5% (33/40) of significantly enhancing adenomas were IHCAs, while only 4% (1/40) were in the HHCA subgroup (p < 0.001). When Gd-EOB uptake behavior was considered in conjunction with established MRI features (binary regression model), the area under the curve (AUC) increased from 0.785 to 0.953 for differentiation of IHCA (atoll sign + hyperintensity), from 0.859 to 0.903 for bHCA (scar + hyperintensity), and from 0.899 to 0.957 for HHCA (steatosis + hypointensity). Three-dimensional region of interest (3D ROI) analysis showed significantly increased voxel heterogeneity for IHCAs (p = 0.038). CONCLUSION: Gd-EOB MRI is of added value for subtype differentiation of HCAs and reliably identifies the typical heterogeneous HBP uptake of IHCAs. Diagnostic accuracy can be improved significantly by the combined analysis of established morphologic MR appearances and intralesional Gd-EOB uptake. KEY POINTS: • Gd-EOB-enhanced MRI is of added value for subtype differentiation of HCA. • IHCA and HHCA can be identified reliably based on their typical Gd-EOB uptake patterns, and accuracy increases significantly when additionally taking established MR appearances into account. • The small numbers of bHCAs and UHCAs remain the source of diagnostic uncertainty. |
format | Online Article Text |
id | pubmed-8645538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-86455382021-12-08 Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Auer, Timo Alexander Fehrenbach, Uli Grieser, Christian Penzkofer, Tobias Geisel, Dominik Schmelzle, Moritz Müller, Tobias Bläker, Hendrik Seehofer, Daniel Denecke, Timm Eur Radiol Hepatobiliary-Pancreas PURPOSE: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI). MATERIALS AND METHODS: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (standard of reference: surgical resection). Two blinded radiologists performed quantitative measurements (lesion-to-liver enhancement) and evaluated qualitative imaging features. Inter-reader variability was tested. Advanced texture analysis was used to evaluate lesion heterogeneity three-dimensionally. RESULTS: Overall, there were 19 (24%) hepatocyte nuclear factor (HNF)-1a-mutated (HHCAs), 37 (47%) inflammatory (IHCAs), 5 (6.5%) b-catenin-activated (bHCA), and 18 (22.5%) unclassified (UHCAs) adenomas. In the hepatobiliary phase (HBP), 49.5% (39/79) of all adenomas were rated as hypointense and 50.5% (40/79) as significantly enhancing (defined as > 25% intralesional GD-EOB uptake). 82.5% (33/40) of significantly enhancing adenomas were IHCAs, while only 4% (1/40) were in the HHCA subgroup (p < 0.001). When Gd-EOB uptake behavior was considered in conjunction with established MRI features (binary regression model), the area under the curve (AUC) increased from 0.785 to 0.953 for differentiation of IHCA (atoll sign + hyperintensity), from 0.859 to 0.903 for bHCA (scar + hyperintensity), and from 0.899 to 0.957 for HHCA (steatosis + hypointensity). Three-dimensional region of interest (3D ROI) analysis showed significantly increased voxel heterogeneity for IHCAs (p = 0.038). CONCLUSION: Gd-EOB MRI is of added value for subtype differentiation of HCAs and reliably identifies the typical heterogeneous HBP uptake of IHCAs. Diagnostic accuracy can be improved significantly by the combined analysis of established morphologic MR appearances and intralesional Gd-EOB uptake. KEY POINTS: • Gd-EOB-enhanced MRI is of added value for subtype differentiation of HCA. • IHCA and HHCA can be identified reliably based on their typical Gd-EOB uptake patterns, and accuracy increases significantly when additionally taking established MR appearances into account. • The small numbers of bHCAs and UHCAs remain the source of diagnostic uncertainty. Springer Berlin Heidelberg 2020-02-21 2020 /pmc/articles/PMC8645538/ /pubmed/32086574 http://dx.doi.org/10.1007/s00330-020-06726-8 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Hepatobiliary-Pancreas Auer, Timo Alexander Fehrenbach, Uli Grieser, Christian Penzkofer, Tobias Geisel, Dominik Schmelzle, Moritz Müller, Tobias Bläker, Hendrik Seehofer, Daniel Denecke, Timm Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title | Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title_full | Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title_fullStr | Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title_full_unstemmed | Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title_short | Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? |
title_sort | hepatocellular adenomas: is there additional value in using gd-eob-enhanced mri for subtype differentiation? |
topic | Hepatobiliary-Pancreas |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645538/ https://www.ncbi.nlm.nih.gov/pubmed/32086574 http://dx.doi.org/10.1007/s00330-020-06726-8 |
work_keys_str_mv | AT auertimoalexander hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT fehrenbachuli hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT grieserchristian hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT penzkofertobias hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT geiseldominik hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT schmelzlemoritz hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT mullertobias hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT blakerhendrik hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT seehoferdaniel hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation AT denecketimm hepatocellularadenomasisthereadditionalvalueinusinggdeobenhancedmriforsubtypedifferentiation |